In trading on Tuesday, shares of Twist Bioscience Corp (Symbol: TWST) entered into oversold territory, hitting an RSI reading of 29.5, after changing hands as low as $34.35 per share. By ...

Twist Bioscience (TWST) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price ...

Auburn guard Tahaad Pettiford was named to the 247Sports All-Freshman Third Team on Thursday. The first-year Tiger, who earned All-SEC Freshman Team honors just a few days ago, was a crucial piece ...

TD Cowen analyst Brendan Smith maintained a Buy rating on Twist Bioscience (TWST – Research Report) today and set a price target of $58.00. The company’s shares closed yesterday at $39.68.

Investors in Twist Bioscience Corp (Symbol: TWST) saw new options begin trading this week, for the October 17th expiration. One of the key inputs that goes into the price an option buyer is ...

The legend of Derik Queen grows. The 20-year-old Maryland center from Baltimore was named Big Ten Freshman of the Year by both the men’s basketball coaches and media, the conference announced ...

In this article, we are going to take a look at where Twist Bioscience Corporation (NASDAQ:TWST) stands against other best immunology stocks to buy now. Immunology is a rapidly advancing field ...

Dylan Harper made his mark in the final home game of his college career. The star Rutgers freshman set a program record for most points scored in a single season by a true freshman during Sunday ...

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics ...

The LSU Tigers brought in one of the best freshman classes in the nation, and of their 23 commits, 13 enrolled early and will partake in spring practices. LSU begins their spring practice schedule ...

Twist Bioscience Co. (NASDAQ:TWST – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the ten ratings firms that are covering the firm, MarketBeat Ratings reports.